Even something that is "less red" without side effects is a multipl B bannger.
(comon we dont need to explain it all over again - lets no bother getting into that)
And what we have is something that 'targets the bacteria with the method of action breaking the bio film' - see previous ann. its so good the 100B bannger is the super bug antimicrobial drug. (it will make acne/rosacea look like small fry - and they alone big cohorts)
When i say BOT is going big - we are talking really big.
e.g. sofdra alone - target pop (not currently prescribed) 6,300,000 @ 3% = 1B in revenue (highlight "marketable" with auto scripts)
Ann: Botanix $40 Million Capital Raising for Sofdra Rollout, page-196
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.025(8.62%) |
Mkt cap ! $617.6M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.5¢ | 29.5¢ | $3.773M | 12.14M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 105056 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 29998 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |